Keyphrases
Therapeutic Potential
100%
Vancomycin
100%
Antibiotic Synergy
100%
Flavobacterium
100%
Rifampin
66%
Meningitis
50%
Linezolid
50%
Ciprofloxacin
50%
Neonatal Meningitis
33%
Neonate
33%
Meropenem
33%
Clinical Evidence
16%
Sepsis
16%
In Vitro Activity
16%
Gram-negative Bacilli
16%
Clinical Efficacy
16%
Optimal Therapy
16%
Microtiter
16%
Additive Effect
16%
Fractional Inhibitory Concentration Index
16%
Neonatal nursery
16%
New Quinolone
16%
Tube Dilution
16%
Checkerboard
16%
Dilution Technique
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vancomycin
100%
Elizabethkingia meningoseptica
100%
Meningitis
83%
Rifampicin
66%
Linezolid
50%
Ciprofloxacin
50%
Meropenem
33%
Infection
16%
Quinolone Derivative
16%
Sepsis
16%
Gram Negative Bacterium
16%
Immunology and Microbiology
Meningitis
100%
Elizabethkingia meningoseptica
100%
Neonatal Meningitis
66%
Dilution
66%
Minimum Inhibitory Concentration
33%
Inhibitory Concentration
33%
Gram-Negative Bacteria
33%
Biochemistry, Genetics and Molecular Biology
Vancomycin
100%
Elizabethkingia meningoseptica
100%
Linezolid
50%
Ciprofloxacin
50%
Dilution
33%
Minimum Inhibitory Concentration
16%
Gram Negative Bacterium
16%
Inhibitory Concentration
16%